Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer H Martin

Showing results (41-50 of 184) with videos related to

Pageof 19
Sort By:
British Journal of Clinical Pharmacology|April 8, 2017
When less is more - efficacy with less toxicity at the ED50Simon Dimmitt, Hans Stampfer, Jennifer H Martin
Pharmacology Research & Perspectives|October 28, 2021
Did our pharmacological strategy for COVID-19 fail?Jennifer H Martin, Michelle Baddeley, Richard Head
Pharmacology Research & Perspectives|July 27, 2025
A Unified Explanation for Drug Repurposing and Pharmacological Pleiotropy Based on Classical and Statistical ThermodynamicsRichard Head, Saiful Islam, Jennifer H Martin
Pharmacology Research & Perspectives|January 22, 2025
Melatonin: A Review of the Evidence for Use in Hospital SettingsJosephine A Adattini, Carly Wills, Jennifer H Martin
Pharmacology Research & Perspectives|January 24, 2023
Pharmacology Research & Perspectives: A Decade of ProgressMichael F Jarvis, Emily Davies, Jennifer H Martin
Pharmacology Research & Perspectives|July 10, 2024
Has the human biological interaction with SARS-CoV2 variants entered a pliant "Faustian bargain"?Richard J Head, Marko Popovic, Jennifer H Martin
The Medical Journal of Australia|February 14, 2018
Compassion and evidence in prescribing cannabinoids: a perspective from the Royal Australasian College of PhysiciansJennifer H Martin, Yvonne Bonomo, Adrian Db Reynolds
Internal Medicine Journal|May 16, 2017
Individualised medicine: why we need Bayesian dosingJoni Donagher, Jennifer H Martin, Michael A Barras
British Journal of Clinical Pharmacology|January 2, 2021
Overcoming barriers to implementing precision dosing with 5-fluorouracil and capecitabineJennifer J Schneider, Peter Galettis, Jennifer H Martin
Pharmacy (Basel, Switzerland)|February 9, 2020
Barriers and Challenges in Performing Pharmacokinetic Studies to Inform Dosing in the Neonatal PopulationKate O'Hara, Jennifer H Martin, Jennifer J Schneider
Pageof 19

Showing results (41-50 of 184) with videos related to

Sort By:
Pageof 19
British Journal of Clinical Pharmacology|April 8, 2017
When less is more - efficacy with less toxicity at the ED50Simon Dimmitt, Hans Stampfer, Jennifer H Martin
Pharmacology Research & Perspectives|October 28, 2021
Did our pharmacological strategy for COVID-19 fail?Jennifer H Martin, Michelle Baddeley, Richard Head
Pharmacology Research & Perspectives|July 27, 2025
A Unified Explanation for Drug Repurposing and Pharmacological Pleiotropy Based on Classical and Statistical ThermodynamicsRichard Head, Saiful Islam, Jennifer H Martin
Pharmacology Research & Perspectives|January 22, 2025
Melatonin: A Review of the Evidence for Use in Hospital SettingsJosephine A Adattini, Carly Wills, Jennifer H Martin
Pharmacology Research & Perspectives|January 24, 2023
Pharmacology Research & Perspectives: A Decade of ProgressMichael F Jarvis, Emily Davies, Jennifer H Martin
Pharmacology Research & Perspectives|July 10, 2024
Has the human biological interaction with SARS-CoV2 variants entered a pliant "Faustian bargain"?Richard J Head, Marko Popovic, Jennifer H Martin
The Medical Journal of Australia|February 14, 2018
Compassion and evidence in prescribing cannabinoids: a perspective from the Royal Australasian College of PhysiciansJennifer H Martin, Yvonne Bonomo, Adrian Db Reynolds
Internal Medicine Journal|May 16, 2017
Individualised medicine: why we need Bayesian dosingJoni Donagher, Jennifer H Martin, Michael A Barras
British Journal of Clinical Pharmacology|January 2, 2021
Overcoming barriers to implementing precision dosing with 5-fluorouracil and capecitabineJennifer J Schneider, Peter Galettis, Jennifer H Martin
Pharmacy (Basel, Switzerland)|February 9, 2020
Barriers and Challenges in Performing Pharmacokinetic Studies to Inform Dosing in the Neonatal PopulationKate O'Hara, Jennifer H Martin, Jennifer J Schneider
Pageof 19